Pallas Capital Advisors LLC Ironwood Pharmaceuticals Inc Transaction History
Pallas Capital Advisors LLC
- $2.43 Billion
- Q2 2025
A detailed history of Pallas Capital Advisors LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 79,512 shares of IRWD stock, worth $63,609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,512
Previous 14,340
454.48%
Holding current value
$63,609
Previous $20,000
185.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IRWD
# of Institutions
222Shares Held
167MCall Options Held
11.2MPut Options Held
6.9K-
Black Rock Inc. New York, NY22.9MShares$18.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$13.1 Million6.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$12.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY13.7MShares$11 Million0.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.94MShares$7.95 Million0.02% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $123M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...